Investor Hot Seat - May 20, 2021
Featured Speakers
Master of Ceremonies
|
|
Master of Ceremonies
John Nemanic, Partner, Green Coast Capital
John Nemanic is a partner in Green Coast Capital International S.A. Green Coast is an international investor providing flexible and innovative financing to the small-cap and micro-cap marketplace in a variety of sectors. Our team consists of experts in capital markets making quick decisions to provide growth capital to issuers.
John is a serial entrepreneur and investor. As co-founder, Chairman and CEO, he exited 3 very successful Internet start ups. In 2006, Hostopia raised 29.2 million (TSX:H), then sold to Deluxe Communications for $124 Million USD. Tucows was sold to the Steinmetz Group for $45 Million April 1999. Tucows current market cap. is over $600 Million. Internet Direct was merged with Look Communications in 1999 with a deemed value of $560 Million John's current interests are medical cannabis, cultivation, hemp and CBD start ups, with a focus on Colombia. He is married to Sandra Carrillo MD a leading expert in Cannabis for clinical applications, and was appointed as "Clinical professor in charge of the scientific program for cannabis research and education", Faculty of Medicine, University of Panama. John manages Panamanian and Colombian based businesses. He is a former member of EO Panama and has extensive contacts within Panama. He also is a former member of EO Toronto (1995) and YPO Toronto (1999). He is actively seeking high-return opportunities to invest in and serve as a director for high-quality cannabis oriented firms. If you are seeking a highly experienced operator, a dynamic leader who understands the growth cycles of start-ups, and how to develop exit strategies please contact John Nemanic. About Green Growth Partners Green Coast Capital International S.A is a private international investment firm focused on investing in small- and micro-cap publicly traded growth companies. We provide flexible debt and equity structured investments across several international markets. We seek to invest in high growth and distressed situations. Green Coast Capital International S.A allocates capital across all industries in four core strategies: discounted equity, convertible debt, convertible preferred equity, and undervalued open market opportunities. We only manage our own capital giving us the ability to make timely and qualified investment decisions.
|
Cindy Ullman, Cofounder, GoodFOR
Cindy Ullman is the Co-Founder of GoodFOR, Inc. GoodFOR’s breakthrough pain products are superior to any other pain topical.
About GoodFOR GoodFOR’s breakthrough pain products are superior to any other pain topical. They work to relieve aches and pains in seconds, last longer, and are far less expensive. They are so extraordinarily good for pain relief of all kinds that the company guarantees their effectiveness, or double your money back. As good for health as they are, they are even better for investors who recognize the wealth value. The Company’s global trademarks make it extremely attractive to sell to a buyer with healthcare, beauty, performance, and an infinite array of consumer products and services Name of Company: GoodFOR, Inc. Website: www.goodfor.us Email: [email protected] LinkedIn: www.linkedin.com/in/cindy-ullman |
David Traylor, Senior Managing Director, Golden Eagle Partners
David Traylor is Senior Managing Director at Golden Eagle Partners, a firm he founded in 2012 to advise life science companies. After advising on various transactions in the life science sector, he took an interest in the cannabis sector and started advising cannabis companies in 2013. In 2014, he joined Surna, Inc. (OTC:SRNA) as Chief Business Officer. After close to a year stint at Surna, Mr. Traylor re-founded Golden Eagle Partners to provide his knowledge to companies across the cannabis sector. Before Golden Eagle Partners, Mr. Traylor served at leading investment banking firms including Pacific Growth Equities (which later became Wedbush), Caris & Company and Headwaters MB (which later became Capstone Headwaters). During his banking tenures he has advised private and public biotechnology and medical device companies in various transactions including IPOs, public offerings, private offerings, mergers and acquisitions totaling over $500 million in value.
Before investment banking, Mr. Traylor spent fifteen years in diverse operational roles in biotechnology companies, from research and development to business development, manufacturing, program management and senior management. He began his career in biotechnology, with a position in bioprocess manufacturing at Synergen (acquired by Amgen), and then moved into R&D and process development positions at Somatogen, a company pursuing a recombinant blood substitute. After Somatogen (acquired by Baxter), he led the management of programs and development initiatives at Affymetrix (acquired by Thermo Fisher), the leading innovator in microarray technology. Mr. Traylor began his business development career at Deltagen then moved over the lead the U.S. operations for atugen AG (acquired by Silence Therapeutics), a Berlin-based functional genomics company. At Bioseek (acquired by Asterand), David led the business development efforts for one of the first systems biology companies. In 1988, Mr. Traylor was one of five Colorado players selected to play for the Denver Rifles in the American Lacrosse League (ALL) – the first U.S. professional field lacrosse league. Mr. Traylor is parlaying his athletic background and knowledge in cannabis as a valuable member of Athletes for Care. He received B.A. degrees from the University of Colorado, Boulder in Biochemistry and Molecular, Cellular and Developmental Biology and an M.B.A. from the Leeds School of Business at the University of Colorado-Boulder. He is also the inventor on three issued U.S. patents. Mr. Traylor is a registered representative and has passed the FINRA Series 7, 63 and 66 examinations. David Traylor is registered in the following states: CA, CO, CT, FL, IL, MA, NV, NJ, NY, OR, PR, TX, WA. About Golden Eagle Partners A Trusted Advisor to Cannabis Leaders. Our combined experience in the early stages of the cannabis and life science sectors helps us confidently close strategic and financing transactions that match the near- and long-term goals of our clients. We specialize in mergers, acquisitions, reverse mergers, financings and incremental transactions such as licensing, joint ventures and co-development arrangements.
|
Dr. David Cunic, CEO, U.C.S. Advisors
David M. Cunic is an entrepreneur who specializes in Investor Relations Advisory services. "Dr. David", as most people know him as, has raised capital, expanded several companies, and has employed over 300+ people. He has been in the medical field for 18+ years, has been a business owner for 19+ years, and has been in the cannabis industry for 10+ years. Some people have called him the "triple headed dragon" due to his diversity and experience. Over the past 16 years, Dr. David has started over 10+ companies, in both the public and private sector, and has successfully sold many of them. His efforts in business operations and human resources won him the prestigious Alfred Sloan Award for Workplace Programs and Flexibility. David has assisted many companies in securing millions of dollars for his clients ranging from the cannabis, hemp, energy, medical, water, and the beverage industry. He has served on numerous boards as an advisor and trusted source of information. Dr. David also performs presentations and speaks at conferences on a variety of topics in both the medical sector and cannabis industry.
|
Jeff Ullman, CEO & Cofounder, GoodFOR
Jeff Ullman is a multiple serial entrepreneur. Most experts declare entrepreneurs should not admit their defeats but as a life-long entrepreneur I've had a challenging life making lives healthier, wealthier & happier. Changing consumer behavior can be punishing: I know the thrill of ascending unclimbed mountains (making million$ for myself & partners) along with the humility in falling from grace (with grace): Entrepreneur vs. EntreMANURE.
In 1976 I created my first breakthrough socially responsible company, Great Expectations Video Dating and helped 100,000+ couples marry. In the '80's & '90s co-created 2400+ hours of TV series: Love Connection (12 seasons); TailDaters (4 seasons); Authored: The Singles Almanac; 12 Secrets for Helping Find Love & Commitment; The Lost Love Life of the Workaholic. I loved helping change romance for the ages. Yet it wasn't long ago when people scoffed at 'losers'; singles who chose a new route to happiness by opting for modern search tools like video dating. Critics cried: "No one will pay to find love!" (Yet I was the first to prove it untrue & exited quite successfully) My wife Cindy & I created Twoology.com to help couples stay happily together by remembering their Relationship ABCs: Always Be Courting. (Another successful exit) I've raised million$ for charities; am a non-monotonous monogamist & a devoted dad. In 2013 I quietly entered the medical cannabis industry helping match people with information that was good for them. In 2015 I created the YPO (Young Presidents Organization) Cannabis Industry Wealth & Health Group. In 2016 I dived deeply into pharmacogenetic testing to save my wife's life from Stage 4 metastatic breast cancer: found the right researchers, clinicians & cannabis. She's healthy! In 2018 my wife, Cindy Ullman, and I created GoodFOR® and invite you to exceed your expectations by finding the wellness products which can be good for you and your loved ones. About GoodFOR GoodFOR’s breakthrough pain products are superior to any other pain topical. They work to relieve aches and pains in seconds, last longer, and are far less expensive. They are so extraordinarily good for pain relief of all kinds that the company guarantees their effectiveness, or double your money back. As good for health as they are, they are even better for investors who recognize the wealth value. The Company’s global trademarks make it extremely attractive to sell to a buyer with healthcare, beauty, performance, and an infinite array of consumer products and services
|
Josh Kincaid, Portfolio Risk Manager, C3 Fund
In a galaxy far far away, Josh was a Securities Risk Analyst managing a $650 million fund in the Investment Banking Industry with proven success in finance, compliance, and operations within a highly regulated industry. He’s experienced the Financial Industry’s stringent regulatory environment and survived a myriad of regulatory changes in the Cannabis Industry.
Yet remains informed of potential changes that could impact the industry, to best leverage his client’s resources and maximize success. Josh has been connecting individuals and businesses within all facets of the supply chain since his internship at the World Trade Center. He keeps a finger on the pulse of the industry utilizing technology and data from HeadSet, New Frontier Data and the Cannabis Alliance, remaining informed by analyzing economic market reactions over the last 6 years. In his spare time, he produces a cannabis business podcast called The Talking Hedge. Josh is an advisor, as well as a Capital Market Analyst, Director of Finance and contract CFO for companies throughout North America. He has a degree in International Business Management from Western Washington University and a Masters in Finance from City University of Seattle and intends to leverage his resources and expertise to drive the Cannabis Industry further. About C3 Fund C3 is an innovative FinTech company, who's algorithm uses artificial intelligence-based technical analysis and machine learning, with predictive analytics to invest in niche sectors like cannabis. C3 removes emotions from trading by focusing on automated trading using a proprietary Smart Frequency Trading algorithm which analyzes multiple data points to create potential trades. Smart Frequency Trading benefits our clients with long-term growth as well as capital preservation by utilizing risk management with predictive analytics to help generate above market returns. It does this using a combination of technical, quantitative and cognitive analysis.
|
J
Dr. Sandra Carrillo, Co-Founder, Medican IPS
Dr. Sandra Carrillo earned her Medical Doctor degree from Universidad CES in Medellin, Colombia. She holds a Master’s degree in Aesthetic Medicine from Baleares Island University in Spain and completed a Masters program of Anti-aging and Aesthetic Medicine in Argentina certified by the International Antiaging Society.
Dr. Carrillo further holds a Masters in Health Services Management, Universidad Latina in Panama, and is certified by Pharmacology University, a Medical Cannabis Institute, as an E xpert Doctor in Cannabis Medicine, Puerto Rico. She completed the University of Toronto Faculty of Medicine CCIC.net Cannabis training program for MD’s, Cannaciencia Seminars Bogota, , Curso Actualizacion sobre las Aplicaciones Terapeuticas de los Canabinoides Universidad CES Medicine, Medellin, and Cannaworld Medical Congress, Medellin. Dr. Carrillo is a member of the International Association for Cannabinoid Medicines and completed a Certificate Program in Cannabis Medicine from Oaksterdam University, California. She is an advocate for the Legalization of Cannabinoids for Medical purposes. Sandra is fluent in Spanish and English, and conversational in French. Sandra is a co-founder of the Panama food bank and a volunteer at the Children's Epilepsy Foundation in Panama. About Medicann IPS
|